The findings suggest that bHB could be a therapeutic alternative to a ketogenic diet. The results also highlight the protective role of the gut microbiota and its metabolites in autoimmune…
Clara Delaroque, from Institut Pasteur (France), emphasizes the critical interplay between early-life microbiota and host health, specifically how the use of common food additives impacts the susceptibility to diseases later…
The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.
By suggesting that the diversity and variety of microbial species play a big role in whether the transplanted microbes can successfully colonize a recipient’s gut, the findings could pave the…
The acquisition will enhance its ability to address the needs of a growing market, empowering researchers and industries worldwide.
The live biotherapeutics market is forecasted to exceed $4 billion by 2030, driven by advancements like MaaT013.
Its emergence in the respiratory health sector represents a paradigm shift, offering promising avenues for innovation and investment.
Raphaëlle Bourdet-Sicard from Danone Nutricia Research discusses a study which investigates the use of a mixed prebiotic formulation to enhance iron absorption while mitigating adverse effects on gut microbiota.
Targeting L-kynurenine metabolism could be a therapeutic strategy for managing Crohn’s disease.
The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.
